General Information of the Compound
Compound ID
CP0418344
Compound Name
4-(dimethylamino)-N-[3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-2,4-dioxo-1H-[1]benzothiolo[3,2-d]pyrimidin-8-yl]butanamide
    Show/Hide
Structure
Formula
C29H36N6O4S
Molecular Weight
564.712
Canonical SMILES
COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4cc(NC(=O)CCCN(C)C)ccc4sc3c2=O)CC1
    Show/Hide
InChI
InChI=1S/C29H36N6O4S/c1-32(2)12-6-9-25(36)30-20-10-11-24-21(19-20)26-27(40-24)28(37)35(29(38)31-26)18-15-33-13-16-34(17-14-33)22-7-4-5-8-23(22)39-3/h4-5,7-8,10-11,19H,6,9,12-18H2,1-3H3,(H,30,36)(H,31,38)
    Show/Hide
InChIKey
NTCOZURJKJMLEZ-UHFFFAOYSA-N
Physicochemical Property
logP
3.0156
Rotatable Bonds
10
Heavy Atom Count
40
Polar Areas
102.91
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
9
Complexity
40

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 90645601
ChEMBL ID
CHEMBL3298019
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1.698 nM
   TI
   LI
   LO
   TS
Protein ID: PT01007, Alpha-1B adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1.66 nM
   TI
   LI
   LO
   TS
Protein ID: PT01004, Alpha-1D adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1.66 nM
   TI
   LI
   LO
   TS